The Impact of Early Viral Infections and Graft-Versus-Host Disease on Immune Reconstitution Following Paediatric Stem Cell Transplantation

Scandinavian Journal of Immunology

Volumn 73, Issue 6, 2011, Pages 586-593

  Olkinuora, H ^a   von Willebrand, E ^b   Kantele, J M ^c   Vainio, O ^d   Talvensaari, K ^e   Saarinen Pihkala, U ^a   Siitonen, S ^b   Vettenranta, K ^f  

^a UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d UNIVERSITY OF OULU   (Finland)

^e FINNISH RED CROSS BLOOD SERVICE   (Finland)

^f TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; HYDROXYCHLOROQUINE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; THALIDOMIDE;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHILD; CHILDHOOD LEUKEMIA; CHRONIC GRAFT VERSUS HOST DISEASE; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; VIRUS INFECTION;

ADENOVIRIDAE; ADOLESCENT; B-LYMPHOCYTES; CELL PROLIFERATION; CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS; FLOW CYTOMETRY; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPESVIRUS 4, HUMAN; HUMANS; INFANT; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; T-LYMPHOCYTES; THYMUS GLAND; VIRUS DISEASES; YOUNG ADULT;

EID: 79955405244     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2011.02530.x     Document Type: Article

References (46)

1. Fallen PR, McGreavey L, Madrigal JA et al. Factors affecting reconstitution of the T cell compartment in allogeneic haematopoietic cell transplant recipients. Bone Marrow Transplant 2003;32:1001-14.
2. Peggs KS, Mackinnon S. Immune reconstitution following haematopoietic stem cell transplantation. Br J Haematol 2004;124:407-20.
3. Mackall CL, Granger L, Sheard MA, Cepeda R, Gress RE. T-cell regeneration after bone marrow transplantation: differential CD45 isoform expression on thymic-derived versus thymic-independent progeny. Blood 1993;82:2585-94.
4. Heitger A, Neu N, Kern H et al. Essential role of the thymus to reconstitute naive (CD45RA+) T-helper cells after human allogeneic bone marrow transplantation. Blood 1997;90:850-7.
5. Mackall CL, Bare CV, Granger LA, Sharrow SO, Titus JA, Gress RE. Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing. J Immunol 1996;156:4609-16.
6. Clark FJ, Gregg R, Piper K et al. Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cells. Blood 2004;103:2410-6.
7. Hazenberg MD, Otto SA, de Pauw ES et al. T-cell receptor excision circle and T-cell dynamics after allogeneic stem cell transplantation are related to clinical events. Blood 2002;99:3449-53.
8. Lewin SR, Heller G, Zhang L et al. Direct evidence for new T-cell generation by patients after either T-cell-depleted or unmodified allogeneic hematopoietic stem cell transplantations. Blood 2002;100:2235-42.
9. Zecca M, Prete A, Rondelli R et al. Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome. Blood 2002;100:1192-200.
10. Filipovich AH, Weisdorf D, Pavletic S et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005;11:945-56.
11. Lee SJ, Klein JP, Barrett AJ et al. Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. Blood 2002;100:406-14.
12. Keever CA, Small TN, Flomenberg N et al. Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts. Blood 1989;73:1340-50.
13. Small TN, Keever CA, Weiner-Fedus S, Heller G, O'Reilly RJ, Flomenberg N. B-cell differentiation following autologous, conventional, or T-cell depleted bone marrow transplantation: a recapitulation of normal B-cell ontogeny. Blood 1990;76:1647-56.
14. Noel DR, Witherspoon RP, Storb R et al. Does graft-versus-host disease influence the tempo of immunologic recovery after allogeneic human marrow transplantation? An observation on 56 long-term survivors. Blood 1978;51:1087-105.
15. Lum LG, Seigneuret MC, Storb RF, Witherspoon RP, Thomas ED. In vitro regulation of immunoglobulin synthesis after marrow transplantation. I. T-cell and B-cell deficiencies in patients with and without chronic graft-versus-host disease. Blood 1981;58:431-9.
16. Kim DH, Kim JG, Sohn SK et al. Clinical impact of early absolute lymphocyte count after allogeneic stem cell transplantation. Br J Haematol 2004;125:217-24.
17. Kim DH, Sohn SK, Won DI, Lee NY, Suh JS, Lee KB. Rapid helper T-cell recovery above 200x10 6/l at 3months correlates to successful transplant outcomes after allogeneic stem cell transplantation. Bone Marrow Transplant 2006;37:1119-28.
18. Wingard JR. Opportunistic infections after blood and marrow transplantation. Transpl Infect Dis 1999;1:3-20.
19. Kim SY, Lee DG, Kim MS, Kim HJ, Lee S, Min CK. The influence of infection early after allogeneic stem cell transplantation on the risk of leukemic relapse and graft-versus-host disease. Am J Hematol 2008;83:784-8.
20. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974;18:295-304.
21. Olkinuora H, Talvensaari K, Kaartinen T et al. T cell regeneration in pediatric allogeneic stem cell transplantation. Bone Marrow Transplant 2007;39:149-56.
22. Kantele A. Antibody-secreting cells in the evaluation of the immunogenicity of an oral vaccine. Vaccine 1990;8:321-6.
23. Anttila PH, von Willebrand E, Simell O. Abnormal immune responses during hypozincaemia in acrodermatitis enteropathica. Acta Paediatr Scand 1986;75:988-92.
24. Stites DP. Clinical laboratory methods for detection of cellular immune function. In: Stites DP, Stobo JD, Fudenberg HH, Wells JV, eds. Basic & Clinical Immunology. Los Altos, CA: Lange Medical Publications, 1984:353-83. ISBN: 0870412248.
25. Miroli AA, James BM, Spitz M. Single step enrichment of human peripheral blood basophils by Ficoll-Paque centrifugation. J Immunol Methods 1986;88:91-6.
26. Koenker R. Quantile Regression. Cambridge: Cambridge University Press, 2005. ISBN: 0-521-60827-9.
27. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
28. Peto R, Pike MC, Armitage P et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer 1977;35:1-39.
29. Small TN, Papadopoulos EB, Boulad F et al. Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions. Blood 1999;93:467-80.
30. Kalwak K, Gorczynska E, Toporski J et al. Immune reconstitution after haematopoietic cell transplantation in children: immunophenotype analysis with regard to factors affecting the speed of recovery. Br J Haematol 2002;118:74-89.
31. Storek J, Dawson MA, Storer B et al. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood 2001;97:3380-9.
32. Roux E, Dumont-Girard F, Starobinski M et al. Recovery of immune reactivity after T-cell-depleted bone marrow transplantation depends on thymic activity. Blood 2000;96:2299-303.
33. Mackall CL, Fleisher TA, Brown MR et al. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1995;332:143-9.
34. Seddik M, Seemayer TA, Lapp WS. T cell functional defect associated with thymid epithelial cell injury induced by a graft-versus-host reaction. Transplantation 1980;29:61-6.
35. Cuss AK, Avery DT, Cannons JL et al. Expansion of functionally immature transitional B cells is associated with human-immunodeficient states characterized by impaired humoral immunity. J Immunol 2006;176:1506-16.
36. Greinix HT, Pohlreich D, Kouba M et al. Elevated numbers of immature/transitional CD21- B lymphocytes and deficiency of memory CD27+ B cells identify patients with active chronic graft-versus-host disease. Biol Blood Marrow Transplant 2008;14:208-19.
37. Avanzini MA, Locatelli F, Dos Santos C et al. B lymphocyte reconstitution after hematopoietic stem cell transplantation: functional immaturity and slow recovery of memory CD27+ B cells. Exp Hematol 2005;33:480-6.
38. Storek J, Saxon A. Reconstitution of B cell immunity following bone marrow transplantation. Bone Marrow Transplant 1992;9:395-408.
39. Sims GP, Ettinger R, Shirota Y, Yarboro CH, Illei GG, Lipsky PE. Identification and characterization of circulating human transitional B cells. Blood 2005;105:4390-8.
40. Duffner UA, Maeda Y, Cooke KR et al. Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease. J Immunol 2004;172:7393-8.
41. Hercend T, Takvorian T, Nowill A et al. Characterization of natural killer cells with antileukemia activity following allogeneic bone marrow transplantation. Blood 1986;67:722-8.
42. Gill S, Olson JA, Negrin RS. Natural killer cells in allogeneic transplantation: effect on engraftment, graft- versus-tumor, and graft-versus-host responses. Biol Blood Marrow Transplant 2009;15:765-76.
43. Farag SS, Fehniger TA, Ruggeri L, Velardi A, Caligiuri MA. Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect. Blood 2002;100:1935-47.
44. Ruggeri L, Capanni M, Urbani E et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002;295:2097-100.
45. de Bruin HG, Astaldi A, Leupers T et al. T lymphocyte characteristics in bone marrow-transplanted patients. II. Analysis with monoclonal antibodies. J Immunol 1981;127:244-51.
46. Witherspoon RP, Lum LG, Storb R. Immunologic reconstitution after human marrow grafting. Semin Hematol 1984;21:2-10.